These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9873746)

  • 1. Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors.
    Perez M; Pauwels PJ; Pallard-Sigogneau I; Fourrier C; Chopin P; Palmier C; Colovray V; Halazy S
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3423-8. PubMed ID: 9873746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice.
    Sànchez C
    Eur J Pharmacol; 1997 Sep; 334(2-3):127-32. PubMed ID: 9369340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
    Gartside SE; Clifford EM; Cowen PJ; Sharp T
    Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC; Sanger DJ
    Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the addition of pindolol accelerate or enhance the response to selective serotonin reuptake inhibitor antidepressants?
    Puzantian T; Kawase K
    Pharmacotherapy; 1999 Feb; 19(2):205-12. PubMed ID: 10030770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of (+/-)-pindolol on the central 5-HT1A receptor by the use of in vivo microdialysis and hippocampal slice preparations].
    Tsuji K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Jun; 22(3):85-95. PubMed ID: 12166089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats.
    Wada Y; Hirao N; Shiraishi J; Nakamura M; Koshino Y
    Neurosci Lett; 1999 May; 267(1):61-4. PubMed ID: 10400249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test.
    Bourin M; Redrobe JP; Baker GB
    Psychopharmacology (Berl); 1998 Apr; 136(3):226-34. PubMed ID: 9566807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
    Hjorth S; Auerbach SB
    Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
    J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
    Oksenberg D; Peroutka SJ
    Biochem Pharmacol; 1988 Sep; 37(18):3429-33. PubMed ID: 2971358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors.
    Newman-Tancredi A; Chaput C; Gavaudan S; Verrièle L; Millan MJ
    Neuropsychopharmacology; 1998 May; 18(5):395-8. PubMed ID: 9536453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    Sánchez C; Hyttel J
    Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.
    Hjorth S; Bengtsson HJ; Milano S
    Eur J Pharmacol; 1996 Nov; 316(1):43-7. PubMed ID: 8982649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.